
NORDIC DRUGS AB NORSK AVDELING AV UTENLANDSK FORETAK NUF
0161 OSLO
Return on Equity
−84,5 %
Current Ratio
3,85
Debt-to-Equity Ratio
−2,29
Key figures (NOK) | 2022 | |
---|---|---|
Revenue | 34Â 083Â 000 | |
Net Income | 5Â 070Â 000 | |
Total Assets | 9Â 865Â 000 | |
Total Equity | −6 000 000 |
Income (NOK) | 2022 | |
---|---|---|
Revenue | 34Â 083Â 000 | |
Expenditure | 27Â 571Â 000 | |
Operating Profit | 6Â 512Â 000 | |
Financial Income | 0 | |
Financial Costs | 5Â 000 | |
Financial Balance | −5 000 | |
Earnings Before Tax | 6Â 507Â 000 | |
Tax | 1Â 436Â 000 | |
Net Income | 5Â 070Â 000 |
Balance (NOK) | 2022 | |
---|---|---|
Total Fixed Assets | 1Â 674Â 000 | |
Total Current Assets | 8Â 191Â 000 | |
Total Assets | 9Â 865Â 000 | |
Total Retained Equity | −6 000 000 | |
Total Equity | −6 000 000 | |
Total Long-Term Debt | 13Â 738Â 000 | |
Total Current Debt | 2Â 127Â 000 | |
Total Equity and Debt | 9Â 865Â 000 |
Cash flow (NOK) | 2022 | |
---|---|---|
Sales Income | 34Â 083Â 000 | |
Other Income | 0 | |
Revenue | 34Â 083Â 000 | |
Cost of Goods Sold | 19Â 358Â 000 | |
Salary Costs | 359Â 000 | |
Depreciation | 0 | |
Impairment | 0 | |
Expenditure | 27Â 571Â 000 | |
Operating Profit | 6Â 512Â 000 | |
Financial Income | 0 | |
Financial Costs | 5Â 000 | |
Financial Balance | −5 000 | |
Dividends | 0 | |
Net Income | 5Â 070Â 000 |
Balance details (NOK) | 2022 | |
---|---|---|
Goodwill | 0 | |
Total Intangible Assets | 1Â 674Â 000 | |
Real Eastate | 0 | |
Machinery and Plant Facilities | 0 | |
Fixtures | 0 | |
Total Tangible Assets | 0 | |
Total Fiancial Fixed Assets | 0 | |
Total Fixed Assets | 1Â 674Â 000 | |
Stock | 0 | |
Total Investments | 0 | |
Cash, Bank | 3Â 986Â 000 | |
Total Current Assets | 8Â 191Â 000 | |
Total Assets | 9Â 865Â 000 | |
Total Equity | −6 000 000 | |
Short-Term Group Debt | 0 | |
Total Long-Term Debt | 13Â 738Â 000 | |
Creditors | 397Â 000 | |
Unpaid Taxes | 1Â 456Â 000 | |
Dividends | 0 | |
Other Current Debt | 274Â 000 | |
Total Current Debt | 2Â 127Â 000 | |
Total Equity and Debt | 9Â 865Â 000 |
Financial indicators | 2022 | |
---|---|---|
Return on Equity | −84,5 % | |
Debt-to-Equity Ratio | −2,29 | |
Operating Profit Margin | 19,11Â % | |
Current Ratio | 3,85 | |
Quick Ratio | 3,85 | |
Equity Ratio | −0,61 | |
Gross Profit Margin | 43,2Â % |
